© 2025 All Rights Reserved.
FDA Accepts Novo Nordisk's Oral Wegovy Application; Stock Jumps
The FDA has accepted Novo Nordisk's application for an oral version of its Wegovy weight-loss medication. The application is based on positive results from a Phase 3 clinical trial. If approved, this would be the first oral GLP-1 treatment for obesity, potentially leading to increased adoption and significant profits. Eli Lilly is also developing a competing weight loss pill.
WSJ
PR Newswire
reuters.com
TipRanks
A 24-Year Battle with Benzodiazepines: A Personal Account of Addiction and Withdrawal
Timothy John Snyder recounts his 24-year addiction to benzodiazepines, starting with a Xanax prescription at age 16. He describes the ineffectiveness of the drugs over time, the horrors of withdrawal, and the lack of proper treatment options. He calls for an end to long-term prescriptions and better care for those struggling with addiction.
Mad In America
Man's 24-Year Battle with Benzodiazepines: A Personal Account of Addiction and Withdrawal
Timothy John Snyder recounts his 24-year addiction to benzodiazepines, starting at age 16 with Xanax and progressing to Klonopin. He details the lack of support for benzo withdrawal, the trap of dependency, and calls for change, urging for shorter prescriptions, better care for long-term users, and an end to the silence surrounding benzo addiction dangers.
Mad In America
West Virginia Cities, Counties Receive $3.5 Million in Lipitor Antitrust Settlement
West Virginia Attorney General JB McCuskey distributed approximately $3.5 million to West Virginia counties and cities as part of a settlement agreement with Pfizer and Ranbaxy over an antitrust lawsuit alleging that the companies conspired to delay the release of a generic version of the cholesterol drug Lipitor, increasing costs for the state's Public Employees Insurance Agency (PEIA).
WDTV 5
WSAZ
WV MetroNews
WV News
West Virginia Cities, Counties Receive $3.5M in Lipitor Antitrust Settlement Funds
West Virginia Attorney General JB McCuskey's office distributed nearly $3.5 million to cities and counties across the state as part of a settlement related to delayed generic versions of Lipitor. The funds, stemming from an antitrust lawsuit against Pfizer and Ranbaxy, aim to reimburse healthcare costs and overpayments. Individual consumers who overpaid for Lipitor may also be eligible for claims.
WDTV 5
waynecountynews.com
herald-dispatch.com
WV News
WV Counties, Cities to Receive $3.5 Million in Lipitor Settlement Funds
West Virginia is distributing nearly $3.5 million to its counties and cities as part of a settlement with Pfizer and Ranbaxy over delaying the release of generic Lipitor. The funds are allocated based on population size, with counties receiving $1,630,000 and cities $1,855,000. The settlement aims to hold pharmaceutical companies accountable for prioritizing profits over affordable medications, with a portion also set aside for individual consumer claims.
WDTV 5
waynecountynews.com
herald-dispatch.com
WV News
Ozempic and Weight Loss: Examining the Craze, Risks, and Cultural Impact
This article explores the increasing use of Ozempic and similar medications for weight loss, initially intended for diabetic patients. It investigates the reasons for its popularity, including celebrity endorsements and social media influence. It also highlights potential risks, side effects, psychological impacts, and the cultural pressures driving its use, especially among women.
LADbible
Yahoo News UK
standardmedia.co.ke
Hindustan Times
Medetomidine Surges in Philadelphia's Drug Supply, Causing Severe Withdrawal
Medetomidine, a veterinary tranquilizer, is rapidly replacing xylazine in Philadelphia's drug supply, leading to severe withdrawal symptoms that are not responding to traditional opioid or xylazine withdrawal treatments. This has resulted in a surge in ICU admissions and highlights the need for better drug testing and treatment protocols.
Inquirer.com
Medetomidine Surges in Illicit Drug Supply, Causing Severe Withdrawal Symptoms
Medetomidine, an animal sedative, is increasingly found in illicit drugs, especially fentanyl, causing severe withdrawal symptoms distinct from opioid or xylazine withdrawal. Reports from Philadelphia, Pittsburgh, and Chicago highlight the drug's rapid spread and the challenges it poses to healthcare providers. Treatment requires intensive care, and dexmedetomidine has shown some effectiveness in managing the withdrawal symptoms. The rise of medetomidine complicates the existing opioid crisis.
Inquirer.com
WYFF
Centers for Disease Control and Prevention | CDC (.gov)
statnews.com
Clarendon Hills Chiropractor Placed on Probation for False Cancer Detection Claims
Dan Ourada, a chiropractor from Clarendon Hills, Illinois, is on probation due to false claims regarding thermography as a breast cancer detection method. The state Department of Financial and Professional Regulations took action after Ourada advertised thermography on his website, making unsubstantiated assertions about its capabilities. The probation requires Ourada to disclose thermography's limitations according to the FDA, American Cancer Society, and American College of Radiology.
Patch
Clarendon Hills Chiropractor Placed on Probation for False Cancer Claims
A chiropractor from Clarendon Hills, working in Lisle, IL, has been placed on professional probation for a year due to false claims made on his website regarding thermography's capabilities in detecting breast cancer. The Illinois Department of Financial and Professional Regulations took action, requiring the chiropractor to include disclaimers about thermography's limitations.
Patch
Clarendon Hills Chiropractor Placed on Probation for False Cancer Claims
A chiropractor from Clarendon Hills, working in Lisle, IL, has been placed on professional probation by the state Department of Financial and Professional Regulations for making unsubstantiated claims about thermography as a breast cancer detection method. A consent decree mandates the chiropractor to include specific disclaimers on his website regarding thermography's limitations.
Patch
Father Muller Homoeopathic Medical College Celebrates World Homoeopathy Day 2025
Father Muller Homoeopathic Medical College (FMHMC) celebrated World Homoeopathy Day 2025 on May 2nd, marking the 270th birth anniversary of Dr. Christian Friedrich Samuel Hahnemann. The event included speeches from dignitaries, awards for students, and a reminder of Homoeopathy's lasting impact. Focus was given to promoting Homoeopathy awareness.
Daijiworld
Weight-Loss Drug Users Report Severe Side Effects: Hair Loss, 'Grotesque' Burps, and More
Reports detail concerning side effects from weight-loss drugs. One woman experienced hair loss and severe gastrointestinal problems, while another reported sulfur burps and other issues while using Mounjaro. Experts warn about using such medications without prescriptions, highlighting the need for caution and medical supervision due to potential risks.
Daily Mail
people.com
The Sun
MSN
Malaysia: Medicine Price Display Rule Sparks Debate Among Doctors, Consumers
Malaysia's new policy mandating medicine price displays in private healthcare and pharmacies has triggered mixed reactions. Consumer groups support it for empowering choices and tackling mark-ups, while some doctors oppose it citing increased burdens and questioning the policy's effectiveness in curbing costs. Pharmacies report minimal impact, having already largely adopted price displays.
Malay Mail
Galen Centre
Malay Mail
The Vibes
Medicine Price Display Rule in Malaysia: Consumer Benefit vs. Doctor Concerns
Malaysia implemented a medicine price display rule on May 1, 2025, aiming to enhance consumer rights and promote informed healthcare choices. While consumer groups support the move, citing increased transparency and tackling excessive mark-ups, private GPs have protested, raising concerns about being regulated under the Price Control and Anti-Profiteering Act and stagnant consultation fees.
Malay Mail
Galen Centre
The Malaysian Reserve
thestar.com.my
NHS Considers Pharmacy Weight Loss Jabs: Broader Access to Ozempic?
The NHS is exploring a pilot program to provide weight-loss injections like Ozempic through pharmacies, potentially broadening access. The move aims to combat obesity, which costs the NHS £6 billion annually. However, concerns exist regarding monitoring, cost-effectiveness, and the potential for misuse. Experts emphasize the need for medical supervision and comprehensive support.
Sky News
BBC
The Telegraph
Daily Mail
State Legislatures Consider Bills to Ease Access to Ivermectin Amidst Controversy
State legislatures in Louisiana and New Hampshire are considering measures to make Ivermectin more accessible, reigniting debates about its use, particularly concerning COVID-19. Proponents argue for patient freedom and doctor-patient relationships, while opponents emphasize the lack of scientific evidence supporting its effectiveness against COVID-19 and potential safety risks, referring to FDA warnings and the importance of scientific consensus.
kplctv.com
WMUR
UnionLeader.com
Shreveport Times
States Consider Over-the-Counter Ivermectin Access Amidst Controversy, Conflicting Evidence
Several states are considering legislation to permit the sale of ivermectin without a prescription, sparking debate due to the drug's controversial history as a purported COVID-19 treatment. While some proponents emphasize patient freedom and potential benefits, concerns remain regarding its unproven efficacy for various conditions and potential health risks, including overdoses.
kplctv.com
Winston-Salem Journal
NORTHEAST - NEWS CHANNEL NEBRASKA
WMUR
Legislators Push for Easier Ivermectin Access Amidst Medical Debate and Past Controversies
State legislatures in Louisiana and New Hampshire are debating bills that would expand access to ivermectin, an anti-parasitic drug. These efforts come amid ongoing debates about ivermectin's effectiveness against COVID-19 and concerns about its potential misuse. The bills are facing opposition from medical professionals and some lawmakers who advocate for evidence-based medical policy.
kplctv.com
WMUR
UnionLeader.com
Shreveport Times
